ChromaDex (CDXC) Tops Q2 EPS by 2c

ChromaDex (NASDAQ: CDXC) reported Q2 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $23.33 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• Citi Adds Four Names to Catalyst Call List
• Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance